ASIT biotech appoints Yves Désiront as new Chairman of the Board of Directors

– BELGIUM, Angleur –  ASIT biotech (BSE: ASIT, EBR: ASIT), a clinical-stage biopharmaceutical company focused on the research and development of breakthrough immunotherapy products for the treatment of allergies, today announced that during the board of directors’ meeting of January 16, 2020, Harry Welten and Jean-Paul Prieels informed the board of directors of their intention to resign as directors at the next general meeting of the company.…

Advicenne nominates Dr David Horn Solomon for election to its Board as Chairman alongside Dr Luc-André Granier remaining as CEO

– FRANCE, Nîmes – Advicenne (BSE: ADVIC, EPA: ADVIC), a speciality pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney disease, today announced its intention to appoint Dr David Horn Solomon as Chairman of its Board of Directors alongside Dr Luc-André Granier who intends to remain CEO as well as a member of the Board of Directors.…